@Jdmoney the P2 is not only breast cancer it’s an all comers trials. Haven’t seen other biotechs go ‘all-in’ by starting a basket trial, either crazy or confident (your choice). Bisantrene could be like Bruce Lee’s 1-inch punch to cancer and cardiotoxicity. Looking forward to trials kicking off H2 - 2024!
Cardioprotection thread, page-700
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $311.7M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |